24/7 Patient Assistance: 760-405-8205

Mary L. Keohan, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Mary Keohan is a medical oncologist in New York. She earned her medical degree from St. George's University School of Medicine and did a residency at Cooper University Hospital. Dr. Keohan obtained her medical degree from New York Presbyterian Hospital and has been in practice for over 20 years. She is certified by the American board in medical oncology and in currently affiliated with Memorial Sloan Kettering Cancer Center.

  • Education & Training


    St. George\'s University School of Medicine

    Medical School


    University of Medicine and Dentistry of New Jersey



    Columbia University College of Physicians & Surgeons


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Memorial Sloan Kettering Cancer Center

    Languages: English/Spanish

    (212) 639-2000

    1275 York Ave

    New York, New York 10065

    Read More
  • Publications & Memberships

    Dr. Mary L. Keohan has contributed to 3 publications.

    Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.

    Gounder, M.,Desai, V.,Kuk, D.,Agaram, N.,Arcila, M.,Durham, B.,Keohan, M. L.,Dickson, M. A.,D'Angelo, S. P.,Shukla, N.,Moskowitz, C.,Noy, A.,Maki, R. G.,Herrera, D. A....; Eur. J. Cancer. 2015 Aug 25

    See more >>

    A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.

    Munhoz, R. R.,D'Angelo, S. P.,Gounder, M. M.,Keohan, M. L.,Chi, P.,Carvajal, R. D.,Singer, S.,Crago, A. M.,Landa, J.,Healey, J. H.,Qin, L. X.,Hameed, M.,Ezeoke, M. O.,...; Oncologist. 2015 Oct 10.

    See more >>

    Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.

    D'Angelo, S. P.,Shoushtari, A. N.,Agaram, N. P.,Kuk, D.,Qin, L.,Carvajal, R. D.,Dickson, M. A.,Gounder, M.,Keohan, M. L.,Schwartz, G. K.,Tap, W. D.; Hum. Pathol.. 2014 Dec 30.

    See more >>


    Connective Tissue Sarcoma Society

    American Society of Clinical Oncology

    Sarcoma Alliance for Research Through Collaboration